Brudaşca I, Cucuianu M, Stancu A, Colhon D M
Clinica Medicală I, Cluj-Napoca, Romania.
Rom J Intern Med. 1994 Jan-Mar;32(1):29-35.
Protein S is a vitamin K-dependent glycoprotein acting as a cofactor for activated protein C and thereby exerting an antithrombotic effect. When compared to values recorded in the 10 healthy normal weight normolipidemic control subjects (80.1% +/- 5.16; mean +/- SEM), plasma protein S-antigen (PS:Ag) level was found to be significantly (p < 0.01) decreased in the 11 patients with decompensated cirrhosis of the liver (54.72% +/- 4.89) and in the 12 surgical patients in critical condition (59.2 +/- 4.96), while obviously (p < 0.001) increased plasma levels were noted in the group including 20 overweight and hyperlipidemic subjects (113% +/- 3.1). Since the low PS:Ag level was associated with a decreased serum cholinesterase (CHE) activity, while both plasma PS:Ag and serum CHE activity were increased in overweight and hyperlipidemic subjects it is considered that impaired or respectively enhanced hepatic protein synthesis is at least partially responsible for changes affecting this antithrombotic plasma protein.
蛋白S是一种维生素K依赖的糖蛋白,作为活化蛋白C的辅因子发挥作用,从而产生抗血栓形成作用。与10名健康正常体重、血脂正常的对照受试者(80.1%±5.16;均值±标准误)的记录值相比,发现11例失代偿期肝硬化患者(54.72%±4.89)和12例危重症手术患者(59.2±4.96)的血浆蛋白S抗原(PS:Ag)水平显著降低(p<0.01),而在包括20名超重和高脂血症受试者的组中血浆水平明显升高(p<0.001)(113%±3.1)。由于低PS:Ag水平与血清胆碱酯酶(CHE)活性降低相关,而超重和高脂血症受试者的血浆PS:Ag和血清CHE活性均升高,因此认为肝脏蛋白合成受损或分别增强至少部分导致了影响这种抗血栓血浆蛋白的变化。